Skip to main content

ORIGINAL RESEARCH article

Front. Endocrinol.
Sec. Pituitary Endocrinology
Volume 15 - 2024 | doi: 10.3389/fendo.2024.1385650

Small pituitary volume and central nervous system anomalies in Fanconi Anemia

Provisionally accepted
  • 1 Departments of Pediatrics and Pediatric Endocrinology, Complejo Hospitalario de Toledo, Toledo, Spain
  • 2 Departments of Pediatrics and Pediatric Endocrinology, Niño Jesús University Children's Hospital, Madrid, Madrid, Spain
  • 3 Department of Pediatric Radiology, Niño Jesús University Children's Hospital, Madrid, Madrid, Spain
  • 4 Department of Pediatric Hematology, Niño Jesús University Children's Hospital, Madrid, Madrid, Spain
  • 5 Fundación para la Investigación del Hospital Niño Jesús, Madrid, Madrid, Spain
  • 6 Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Madrid, Madrid Community, Spain
  • 7 Department of Pediatric Hematology., Niño Jesús University Children's Hospital, Madrid, Madrid, Spain
  • 8 Departments of Pediatrics and Pediatric Endocrinology., Niño Jesús University Children's Hospital, Madrid, Madrid, Spain
  • 9 Institute for Health Research, Princess University Hospital, Madrid, Madrid, Spain
  • 10 Department of Pediatrics, Faculty of Medicine, Autonomous University of Madrid, Madrid, Madrid, Spain
  • 11 CIBER Fisiopatología Obesidad y Nutrición (CIBEROBN), Madrid, Madrid, Spain
  • 12 IMDEA Food Institute, Madrid, Madrid, Spain

The final, formatted version of the article will be published soon.

    Introduction: Fanconi anemia (FA) is a genomic instability disorder associated with congenital abnormalities, including short stature and the presence of central nervous system anomalies, especially in the hypothalamic-pituitary area. Thus, differences in pituitary size could associate with the short stature observed in these patients. Our aim was to evaluate whether central nervous system abnormalities and pituitary gland volume correlate with height and hormone deficiencies in these patients. Methods: In this cross-sectional exploratory study 21 patients diagnosed with FA between 2017 and 2022 in a Spanish Reference Center were investigated. Magnetic resonance imaging (MRI) was performed and pituitary volume calculated and corelated with height and other endocrine parameters. Results: The percentage of abnormalities in our series was 81%, with a small pituitary (pituitary volume less than 1 SD) being the most frequent, followed by Chiari malformation type 1. The median value of pituitary volume was -1.03 SD (IQR: -1.56, -0.36). Short stature was found in 66.7% (CI95% 43-85.4). Total volume (mm 3) increases significantly with age and in pubertal stages. There were no differences between volume SD and pubertal stage, or the presence of endocrine deficiencies. No correlations were found between pituitary volume and the presence of short stature. The intraclass correlation index (ICC) average for volume was 0.85 (CI95% 0.61-0.94) indicating a good-to-excellent correlation of measurements. Discussion: Central nervous system anomalies are part of the FA phenotype, the most frequent after pituitary hypoplasia being posterior fossa abnormalities, which may have clinical repercussions in the patient. It is therefore necessary to identify those who could be candidates for neurosurgical intervention. The size of the pituitary gland is smaller in these patients, but this does not seem to be related to hormone deficiency and short stature or exposure to a low dose of total body radiation.

    Keywords: Pituitary Gland, pituitary volume, Fanconi Anemia, Magnetic Resonance Imaging, short stature

    Received: 10 May 2024; Accepted: 30 Jul 2024.

    Copyright: © 2024 Corredor, Solís, Zubicaray, Sevilla and Argente. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Beatriz Corredor, Departments of Pediatrics and Pediatric Endocrinology, Complejo Hospitalario de Toledo, Toledo, Spain

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.